DXB 3.06% 47.5¢ dimerix limited

General Discussion, page-48

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274

    2.6 Role of the funding source

    The study was overseen by the Hokuriku Clinical Research Supporting Center. The data centre of the innovative clinical research centre of Kanazawa University managed and handled all data. The statistical department of the centre was involved in the analysis of data. All authors had access to study results, and the lead author takes responsibility for the accuracy and completeness of the data reported. The lead author had the final decision to submit the publication.

    This study was supported by a Grant‐in‐Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI) Grant number 26893095. Although the study drug was provided by the Sanwa Kagaku Kenkyusho Co., Ltd, the company had no role in the design of the study; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the article for publication.

    Hi Rad,

    The authors of this study have reported no conflict of interest, although they did receive some funding for the study & drugs supplied, funding source statement above.

    Not worried about any of this & an interesting read. Thanks @Flotsam for posting.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
47.5¢
Change
-0.015(3.06%)
Mkt cap ! $261.3M
Open High Low Value Volume
49.5¢ 49.5¢ 46.5¢ $2.742M 5.746M

Buyers (Bids)

No. Vol. Price($)
3 158396 47.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 162500 2
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.